Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Before starting a small business, it's crucial to know what you need. This guide outlines the essential tools and resources for success.
22,606 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
Two very different aerospace players compete for a spot on ambitious investors' lists. Archer Aviation aims to redefi...
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...
Tesla faced a rocky period, but a few hopeful indicators suggest the EV leader may be on a steadier path. This articl...
Opendoor Technologies stock down discordant headlines have traders wondering if a rebound is possible. This article b...
Protests ignite in Nairobi as fuel costs surge and a transport strike widens disrupted daily life; schools shift onli...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...
A chief revenue officer at a growing restaurant-tech company recently sold a sizable block of stock. Insider moves li...
June markets stay choppy as Aurora Innovation slides on Uber stake actions. This guide breaks down what it means for ...
New research shows AI projects struggle to deliver ROI unless companies redesign roles, workflows, and incentives. Ex...